TWI463980B - 醫藥組成物 - Google Patents

醫藥組成物 Download PDF

Info

Publication number
TWI463980B
TWI463980B TW099138635A TW99138635A TWI463980B TW I463980 B TWI463980 B TW I463980B TW 099138635 A TW099138635 A TW 099138635A TW 99138635 A TW99138635 A TW 99138635A TW I463980 B TWI463980 B TW I463980B
Authority
TW
Taiwan
Prior art keywords
volatile
solvent
pharmaceutical composition
active ingredient
concentration
Prior art date
Application number
TW099138635A
Other languages
English (en)
Chinese (zh)
Other versions
TW201116274A (en
Inventor
Francis Davis Adrian
Original Assignee
Futura Medical Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Futura Medical Dev Ltd filed Critical Futura Medical Dev Ltd
Publication of TW201116274A publication Critical patent/TW201116274A/zh
Application granted granted Critical
Publication of TWI463980B publication Critical patent/TWI463980B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW099138635A 2009-11-10 2010-11-10 醫藥組成物 TWI463980B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919650.2A GB0919650D0 (en) 2009-11-10 2009-11-10 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
TW201116274A TW201116274A (en) 2011-05-16
TWI463980B true TWI463980B (zh) 2014-12-11

Family

ID=41502143

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099138635A TWI463980B (zh) 2009-11-10 2010-11-10 醫藥組成物

Country Status (11)

Country Link
US (1) US9358219B2 (pt)
EP (1) EP2498770B1 (pt)
CN (1) CN102711751B (pt)
AU (1) AU2010317732B2 (pt)
BR (1) BR112012011126A2 (pt)
CA (1) CA2776797C (pt)
ES (1) ES2724173T3 (pt)
GB (1) GB0919650D0 (pt)
NZ (1) NZ599599A (pt)
TW (1) TWI463980B (pt)
WO (1) WO2011058351A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010085589A2 (en) 2009-01-22 2010-07-29 G&H Brands Llc Desensitizing drug product
WO2012150891A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Composition for administration of a pharmacologically or cosmetically active agent onto a surface of a living organism

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325990B1 (en) * 1995-10-20 2001-12-04 Laboratoire L. Lafon Film forming composition for spraying on the skin
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
US20020006435A1 (en) * 2000-01-27 2002-01-17 Samuels Paul J. Transdermal anesthetic and vasodilator composition and methods for topical administration
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US20050209319A1 (en) * 2004-03-18 2005-09-22 Xenoport, Inc. Treatment of local pain
FR2867682B1 (fr) 2004-03-22 2009-06-05 Galderma Res & Dev Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2887150B1 (fr) 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6325990B1 (en) * 1995-10-20 2001-12-04 Laboratoire L. Lafon Film forming composition for spraying on the skin
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation

Also Published As

Publication number Publication date
AU2010317732B2 (en) 2016-03-24
CA2776797A1 (en) 2011-05-19
CA2776797C (en) 2018-02-20
NZ599599A (en) 2014-06-27
WO2011058351A3 (en) 2011-12-08
CN102711751B (zh) 2015-11-25
ES2724173T3 (es) 2019-09-06
AU2010317732A1 (en) 2012-05-10
BR112012011126A2 (pt) 2017-12-12
US9358219B2 (en) 2016-06-07
TW201116274A (en) 2011-05-16
EP2498770A2 (en) 2012-09-19
EP2498770B1 (en) 2019-02-27
CN102711751A (zh) 2012-10-03
US20120248142A1 (en) 2012-10-04
GB0919650D0 (en) 2009-12-23
WO2011058351A2 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
RU2754846C1 (ru) Обезболивающие композиции местного действия
US20180344743A1 (en) Methods of treatment of anorectal and genital disorders
EP2131813B1 (en) Topical pharmaceutical formulation
JP5972862B2 (ja) 熱ゲル化麻酔組成物
US20080027033A1 (en) Method and Composition for Treatment of Cutaneous Lesions
JPH02191214A (ja) 医薬活性剤の経皮デリバリー用組成物
JP2006527734A (ja) 局所投与のための麻酔用組成物
US20050014823A1 (en) Topical anesthetic composition and method of administration
TWI463980B (zh) 醫藥組成物
JP2003012501A (ja) 鎮痒エアゾール製剤
JP2005089345A (ja) 虫刺され治療薬
TW200803833A (en) Composition for promoting vascular smooth muscle relaxation
KR100586422B1 (ko) 발기부전 치료용 외용제 조성물
WO2020109254A1 (en) New composition of amide and ester local anesthetics and uses thereof
JP2005220052A (ja) 性機能障害治療用外用剤
US20150141518A1 (en) Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation
KR20040094978A (ko) 발기부전 치료용 외용제 조성물

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees